IL6 and tuberculosis: IL-6 plasma concentrations in TB patients have also been shown to decline during antimycobacterial treatment at 6 and 16 weeks (45), supporting the lack of a positive correlation between the plasma levels of IL-6 and the lymphocyte bioenergetic parameters at later time points during therapy.